Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 26, 2025
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
GlobeNewswire
·
March 26, 2025
– Oral presentation to highlight preclinical data further supporting combination of KO-2806 with TKIs in ccRCC – – Company expects to present data from the Phase 1 FIT-001 trial evaluating KO-2806 and cabozantinib in patients with RCC in 2H 2025 – SAN …
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
GlobeNewswire
·
March 26, 2025
Statistically significant and clinically meaningful improvement of 3.8 seconds in Time-to-Rise vs. natural history with largest effect observed relative to any approved dystrophin restoration therapy at 48 weeks; additional functional benefits observed in …
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
GlobeNewswire
·
March 26, 2025
Event to highlight the differentiated features of Traws oral small molecule product candidates: Tivoxavir Marboxil, a single dose, CAP-dependent endonuclease inhibitor for Bird Flu Ratutrelvir, a main protease inhibitor, to be used without ritonavir, for …
Entourage Health Increases Senior Secured Credit Facility
GlobeNewswire
·
March 26, 2025
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it has entered into …
PurDentix Probiotic Supplement: Ingredients, Benefits, Reviews & Where to Buy
GlobeNewswire
·
March 26, 2025
AURORA, Colo., March 26, 2025 (GLOBE NEWSWIRE) -- Maintaining optimal oral health is more crucial than ever in today's unhealthy world. Many struggle with gum disease, tooth decay, and oral hygiene, leading to a growing interest in innovative solutions. …
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
GlobeNewswire
·
March 26, 2025
Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional anti-PD1-IL2 Superkine, MDNA113, will also be presented TORONTO and HOUSTON, March …
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
GlobeNewswire
·
March 26, 2025
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning mid-2025 Multiple data readouts in mid and late 2025 on track for MET-233i, an ultra-long acting …
Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
GlobeNewswire
·
March 26, 2025
ADOPT Study Findings Highlight Nanox.AI’s Role in Enhancing Fracture Detection and Healthcare Cost Savings PETACH TIKVA, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging …
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
GlobeNewswire
·
March 26, 2025
LONDON and PHILADELPHIA, March 26, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that …
Microbix Further Optimizes Capital Usage and Availability
GlobeNewswire
·
March 26, 2025
MISSISSAUGA, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the further optimization of the structure and utilization of its capital …
Hair Loss Hero: 2DDR HEALTHCARE Shares Results From Customer Driven Hair Loss Research Study
GlobeNewswire
·
March 26, 2025
Dover, Delaware, March 26, 2025 (GLOBE NEWSWIRE) -- 2DDR HEALTHCARE, LLC, a biosciences company based in Dover, Delaware, has published results from several customers that entered an independent research study to determine if 2-deoxy-D-ribose (2dDR) is a …
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
GlobeNewswire
·
March 26, 2025
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
GlobeNewswire
·
March 26, 2025
WAYNE, Pa. and ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, today announced the appointment of Michael Heffernan as Chairman …
Aclarion Announces Reverse Stock Split
GlobeNewswire
·
March 26, 2025
BROOMFIELD, Colo., March 26, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians …
Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd™ Alcohol Detox Product Lineup for Retail Sales
GlobeNewswire
·
March 26, 2025
New Ultra-Portable unbuzzd™ Single-Use Powder Sticks in Convenient 8-Pack Display Boxes Now Available for US Retailers TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “ …
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
GlobeNewswire
·
March 26, 2025
Company reports fourth quarter and full year 2024 XHANCE net revenue of $22.4 million and $78.2 million, increases of 13% and 10% compared to prior year periods Company reports 23% prescription growth from third quarter 2024 to fourth quarter 2024 YARDLEY, …
Auron Therapeutics Announces Poster Presentation at 2025 AACR Annual Meeting
GlobeNewswire
·
March 26, 2025
NEWTON, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the Company will present …
Comiccon de Montréal 2025 : le plus gros rassemblement estival de fans et de superhéros
GlobeNewswire
·
March 26, 2025
MONTRÉAL, 26 mars 2025 (GLOBE NEWSWIRE) -- La 15e édition du Comiccon de Montréal, présentée par Le Journal de Montréal en collaboration avec EBOX, fournisseur Internet, aura lieu du 4 au 6 juillet 2025 au Palais des congrès. À l’occasion de cet événement …
Montreal Comiccon 2025: The Summer’s Biggest Gathering of Fans and Superheroes
GlobeNewswire
·
March 26, 2025
MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- The 15th edition of Montreal Comiccon, presented by Le Journal de Montréal in collaboration with EBOX, Internet Provider, will take place from July 4 to 6, 2025 at the Palais des congrès. The event, one of the …
I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 26, 2025
ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB), a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will …